Ondansetron Teva

Ondansetron, the active ingredient in Ondansetron Teva, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery. GNH USA supplies Ondansetron Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ondansetron Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ondansetron Teva is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways.

- Chemotherapy‑induced nausea and vomiting: Reduces the frequency and severity of nausea and vomiting in patients receiving cytotoxic chemotherapy. - Radiation‑induced nausea and vomiting: Helps prevent the onset of vomiting during or after radiation therapy. - Post‑operative post‑operative vomiting: Provides prophyl and treatment of post‑surgical vomiting. - Ant the     ... - ...  ... ...  - ... …